Stockscreener 앱 받기
42.39
0.19%
0.08
시간 외 거래:
42.68
0.29
+0.68%
전일 마감가:
$42.31
열려 있는:
$42.32
하루 거래량:
1.72M
Relative Volume:
0.74
시가총액:
$5.86B
수익:
$181.74M
순이익/손실:
$-143.97M
주가수익비율:
-30.50
EPS:
-1.39
순현금흐름:
$9.60M
1주 성능:
+11.55%
1개월 성능:
+22.91%
6개월 성능:
+205.18%
1년 성능:
+120.44%
1일 변동 폭
$41.31
$43.69
1주일 범위
$38.63
$43.69
52주 변동 폭
$9.57
$43.69
Arrowhead Pharmaceuticals Inc Stock (ARWR) Company Profile
명칭
Arrowhead Pharmaceuticals Inc
전화
626-696-4702
주소
177 E COLORADO BLVD, PASADENA, CA
ARWR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ARWR
Arrowhead Pharmaceuticals Inc
|
42.39 | 5.85B | 181.74M | -143.97M | 9.60M | -1.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Arrowhead Pharmaceuticals Inc Stock (ARWR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-05 | 개시 | Goldman | Neutral |
| 2023-12-04 | 개시 | BofA Securities | Buy |
| 2023-09-19 | 개시 | Citigroup | Neutral |
| 2023-07-21 | 개시 | TD Cowen | Outperform |
| 2023-05-12 | 다운그레이드 | SVB Securities | Outperform → Market Perform |
| 2023-04-26 | 개시 | SMBC Nikko | Outperform |
| 2023-04-12 | 업그레이드 | SVB Securities | Market Perform → Outperform |
| 2023-03-21 | 개시 | Bernstein | Mkt Perform |
| 2022-09-09 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-05-11 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2022-01-19 | 재개 | Goldman | Buy |
| 2021-08-06 | 재확인 | Chardan Capital Markets | Buy |
| 2021-06-04 | 재개 | Robert W. Baird | Neutral |
| 2021-02-05 | 재확인 | H.C. Wainwright | Buy |
| 2020-12-21 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-12-16 | 개시 | UBS | Buy |
| 2020-11-19 | 개시 | Citigroup | Buy |
| 2020-05-13 | 개시 | RBC Capital Mkts | Outperform |
| 2020-05-08 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2020-04-15 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2020-03-24 | 업그레이드 | SVB Leerink | Underperform → Mkt Perform |
| 2020-03-17 | 개시 | Goldman | Neutral |
| 2020-01-21 | 개시 | SVB Leerink | Underperform |
| 2019-12-13 | 개시 | Oppenheimer | Perform |
| 2019-11-29 | 재확인 | Chardan Capital Markets | Buy |
| 2019-11-27 | 재확인 | B. Riley FBR | Buy |
| 2019-11-25 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2019-10-24 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2019-10-22 | 재확인 | Chardan Capital Markets | Buy |
| 2019-10-03 | 개시 | Robert W. Baird | Outperform |
| 2018-09-07 | 업그레이드 | B. Riley FBR | Neutral → Buy |
| 2018-09-06 | 재확인 | Chardan Capital Markets | Buy |
| 2018-08-08 | 재확인 | Cantor Fitzgerald | Overweight |
| 2018-07-02 | 재확인 | Chardan Capital Markets | Buy |
모두보기
Arrowhead Pharmaceuticals Inc 주식(ARWR)의 최신 뉴스
Why analysts remain bullish on Arrowhead Pharmaceuticals Inc. stockWeekly Trade Analysis & Risk Controlled Daily Trade Plans - newser.com
What dividend safety rating applies to Arrowhead Pharmaceuticals Inc. (HDP1) stockWatch List & Verified Short-Term Plans - newser.com
How sentiment analysis helps forecast Arrowhead Pharmaceuticals Inc.Portfolio Risk Summary & Real-Time Sentiment Analysis - newser.com
Why Arrowhead Pharmaceuticals Inc. is moving todayQuarterly Trade Report & Expert Approved Momentum Ideas - newser.com
Best data tools to analyze Arrowhead Pharmaceuticals Inc. stockQuarterly Performance Summary & Accurate Trade Setup Notifications - newser.com
Will Arrowhead Pharmaceuticals Inc. stock split again soonEarnings Beat & Accurate Technical Buy Alerts - newser.com
Can Arrowhead Pharmaceuticals Inc. stock reach $100 price targetEarnings Overview Report & Daily Technical Stock Forecast Reports - newser.com
How to build a dashboard for Arrowhead Pharmaceuticals Inc. stockPortfolio Value Report & Real-Time Volume Analysis Alerts - newser.com
How to escape a deep drawdown in Arrowhead Pharmaceuticals Inc.Market Activity Report & High Accuracy Investment Signals - newser.com
Is Arrowhead Pharmaceuticals Inc. stock attractive for growth ETFsPortfolio Return Report & Entry and Exit Point Strategies - newser.com
What makes Arrowhead Pharmaceuticals Inc. (HDP1) stock appealing to growth investorsQuarterly Portfolio Summary & Weekly Setup with High ROI Potential - newser.com
Will Arrowhead Pharmaceuticals Inc. stock benefit from upcoming earnings reportsWeekly Investment Report & Stock Portfolio Risk Management - newser.com
Combining price and volume data for Arrowhead Pharmaceuticals Inc.2025 Breakouts & Breakdowns & Technical Pattern Recognition Alerts - newser.com
Arrowhead Pharmaceuticals Advances Phase 3 Study on Plozasiran for Severe Hypertriglyceridemia - MSN
Arrowhead Pharmaceuticals Advances in FSHD1 Treatment with ARO-DUX4 Study - MSN
Is Arrowhead Pharmaceuticals Inc. stock cheap at current valuation2025 Top Gainers & Verified Entry Point Signals - newser.com
How buybacks impact Arrowhead Pharmaceuticals Inc. stock value2025 Trading Recap & Intraday High Probability Setup Alerts - newser.com
Published on: 2025-10-31 04:03:58 - newser.com
Advanced analytics toolkit walkthrough for Arrowhead Pharmaceuticals Inc.Market Performance Report & Verified Momentum Watchlists - newser.com
Is Arrowhead Pharmaceuticals Inc. showing signs of accumulationJuly 2025 Decliners & Short-Term Trading Opportunity Alerts - newser.com
Can Arrowhead Pharmaceuticals Inc. stock sustain revenue growth2025 Performance Recap & Real-Time Chart Breakout Alerts - newser.com
Why Arrowhead Pharmaceuticals Inc. (HDP1) stock signals breakout potentialJuly 2025 Breakouts & Free Reliable Trade Execution Plans - newser.com
Can Arrowhead Pharmaceuticals Inc. stock hit analyst price targetsLong Setup & Technical Pattern Alert System - newser.com
Published on: 2025-10-30 23:19:07 - newser.com
Arrowhead Pharmaceuticals Advances in SCA2 Treatment with ARO-ATXN2 Study - TipRanks
Arrowhead Pharmaceuticals, Inc. (ARWR) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Arrowhead Pharmaceuticals Advances ARO-DM1 Study for Myotonic Dystrophy - TipRanks
Cwm LLC Has $180,000 Stake in Arrowhead Pharmaceuticals, Inc. $ARWR - MarketBeat
Published on: 2025-10-30 00:34:36 - newser.com
Is Arrowhead Pharmaceuticals Inc. (HDP1) stock dividend growth reliableShort Setup & Capital Efficient Trade Techniques - newser.com
Arrowhead Pharmaceuticals (NASDAQ:ARWR) Reaches New 12-Month HighStill a Buy? - MarketBeat
Arrowhead Pharmaceuticals, Inc. (ARWR) Stock forecasts - Yahoo! Finance UK
Arrowhead Pharmaceuticals Inc (ARWR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.62%
0.21%
자본화:
|
볼륨(24시간):